In-vitro test results demonstrated up to 40x native BMP-2 alkaline phosphate levels compared to BMP-2 control.ConCelltrate ® 100

ConCelltrate®100 has histologically demonstrated the presence of all five elements of bone formation including new bone, bone marrow, osteocytes, chondrocytes, and cartilage in the athymic rat post-implantation at 28 days. In-Vivo testing is performed by an independent laboratory on every lot post-sterilization.

About ConCelltrate ® 100

ConCelltrate®100 is processed using a proprietary process.ConCelltrate®100 may be hydrated with saline, blood, BoneMarrow Aspirate (BMA), Platelet Rich Plasma (PRP), or other cellular components in accordance with a physician’s well-informed medical judgment. ConCelltrate®100 does not contain any extrinsic carriers and is entirely derived from100% human allograft bone

Potential Clinical Applications

  • Spine
  • Neurosurgery
  • Orthopedics
  • Trauma
  • Reconstruction
  • Foot & Ankle
  • Dental

Features & Benefits

  • Tested for Osteoinductivity – each lot is assayed and verified
  • Natural human scaffold
  • 100% bone – no additional carrier
  • Ambient storage and shipping temperatures
  • Resists irrigation
  • Sterile – Sterility Assurance Level (SAL) of 10-6 with a Two Year Shelf Life


(Available in Jar) ConCelltrate® 100

ConCelltrate® 100, 1.0 cc 453010
ConCelltrate® 100, 2.5 cc 453025
ConCelltrate® 100, 5.0 cc 453050
ConCelltrate® 100, 10 cc 453100


Cygnus®is a Registered Trademark of Vivex Biomedical Inc.

Please refer to Instructions for use for description, handling, storage parameters, indications, contraindications, warnings, precautions, and other important information. A surgeon must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a particular patient.

Have a question about ConCelltrate®? Have us contact you back.

Request to be contacted back for more information about any of our products. We’ll respond to your request right away.